Skip to main content

Cue Biopharma, Inc.

CUE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001645460

In the last 90 days, Cue Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $52.2M in total; no superinvestor holds it.

13F holders, Q4 2022

Institutional positions in Cue Biopharma, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
61
−3 vs. Q3 2022
Shares held
12.8M
−36.8K (−0.3%) vs. Q3 2022
Total value
$36.4M
+$7.70M (+26.9%) vs. Q3 2022
New holders
12
14 more added
Sold out
15
18 more reduced

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CUE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 61 institutions
Q1 2021: 89 institutionsQ2 2021: 90 institutionsQ3 2021: 89 institutionsQ4 2021: 91 institutionsQ1 2022: 100 institutionsQ2 2022: 76 institutionsQ3 2022: 64 institutionsQ4 2022: 61 institutionsQ1 2023: 63 institutionsQ2 2023: 78 institutionsQ3 2023: 75 institutionsQ4 2023: 80 institutionsQ1 2024: 77 institutionsQ2 2024: 75 institutionsQ3 2024: 50 institutionsQ4 2024: 55 institutionsQ1 2025: 49 institutionsQ2 2025: 47 institutionsQ3 2025: 52 institutionsQ4 2025: 49 institutionsQ1 2026: 57 institutionsQ2 2026: 50 institutions
Value heldQ4 2022: $36.4M
Q1 2021: $229.7MQ2 2021: $216.4MQ3 2021: $245.6MQ4 2021: $187.3MQ1 2022: $86.8MQ2 2022: $35.0MQ3 2022: $28.7MQ4 2022: $36.4MQ1 2023: $43.0MQ2 2023: $50.5MQ3 2023: $32.1MQ4 2023: $39.3MQ1 2024: $31.0MQ2 2024: $17.1MQ3 2024: $10.5MQ4 2024: $12.8MQ1 2025: $10.4MQ2 2025: $11.9MQ3 2025: $13.0MQ4 2025: $6.67MQ1 2026: $4.95MQ2 2026: $52.2M
Institutions holding CUE and their total value by quarter
QuarterHoldersValue
Q2 202650$52.2M
Q1 202657$4.95M
Q4 202549$6.67M
Q3 202552$13.0M
Q2 202547$11.9M
Q1 202549$10.4M
Q4 202455$12.8M
Q3 202450$10.5M
Q2 202475$17.1M
Q1 202477$31.0M
Q4 202380$39.3M
Q3 202375$32.1M
Q2 202378$50.5M
Q1 202363$43.0M
Q4 202261$36.4M
Q3 202264$28.7M
Q2 202276$35.0M
Q1 2022100$86.8M
Q4 202191$187.3M
Q3 202189$245.6M
Q2 202190$216.4M
Q1 202189$229.7M

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Cue Biopharma, Inc.; share changes are against Q3 2022.

Institutions holding CUE in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
JPMorgan Chase & Co39$00.00%00.0%Unchanged
Armstrong Advisory Group, Inc120$3420.00%+120New
BNP Paribas Arbitrage, SA190$5420.00%00.0%Unchanged
Advisory Services Network, LLC200$5700.00%+200New
Accel Wealth Management318$9060.00%00.0%Unchanged
Harbour Investments, Inc.439$1.25K0.00%00.0%Unchanged
FMR LLC484$1.38K0.00%+484New
Kelly Financial Services LLC500$1.43K0.00%+200+66.7%Added
Money Concepts Capital Corp715$2.04K0.00%+715New
Beaird Harris Wealth Management, LLC797$2.27K0.00%00.0%Unchanged
Baker Avenue Asset Management, LP1,750$4.99K0.00%+1,750New
Advisor Group Holdings, Inc.2,062$6.00K0.00%−46,200−95.7%Reduced
Accurate Wealth Management, LLC2,550$7.60K0.00%+2,550New
Barclays PLC6,029$17.2K0.00%−159−2.6%Reduced
Beacon Pointe Advisors, LLC10,000$28.5K0.00%+10,000New
LPL Financial LLC10,570$30.1K0.00%00.0%Unchanged
Jump Financial, LLC11,627$33.1K0.00%+11,627New
Charles Schwab Investment Management Inc12,652$36.1K0.00%00.0%Unchanged
SeaCrest Wealth Management, LLC14,000$39.9K0.01%−2,000−12.5%Reduced
Goldman Sachs Group Inc14,087$40.1K0.00%+110+0.8%Added
Occudo Quantitative Strategies LP14,656$41.8K0.00%−5,548−27.5%Reduced
Citadel Advisors LLC16,018$45.7K0.00%+16,018New
Newbridge Financial Services Group, Inc.17,000$48.5K0.03%00.0%Unchanged
Bank of New York Mellon Corp21,287$60.7K0.00%−42−0.2%Reduced
Connor, Clark & Lunn Investment Management Ltd.22,970$65.5K0.00%−9,707−29.7%Reduced
UBS Group AG24,145$68.8K0.00%00.0%Unchanged
Qube Research & Technologies Ltd28,797$82.1K0.00%+3,372+13.3%Added
Bank of Montreal33,900$98.0K0.00%+33,900New
Acadian Asset Management LLC37,167$104.0K0.00%−26,067−41.2%Reduced
Cubist Systematic Strategies, LLC40,387$115.1K0.00%00.0%Unchanged
Wells Fargo & Company48,121$137.1K0.00%+28,111+140.5%Added
Sanders Morris Harris LLC56,420$160.8K0.06%−791,628−93.3%Reduced
Northern Trust Corp62,589$178.4K0.00%00.0%Unchanged
Annandale Capital, LLC65,000$185.0K0.06%00.0%Unchanged
Jacobs Levy Equity Management, Inc69,522$198.1K0.00%+69,522New
Parallax Volatility Advisers, L.P.75,000$213.8K0.01%00.0%Unchanged
Good Life Advisors, LLC75,000$213.8K0.03%+18,000+31.6%Added
Nantahala Capital Management, LLC93,297$265.9K0.02%00.0%Unchanged
Bank of America Corp97,034$276.5K0.00%−16,478−14.5%Reduced
Two Sigma Advisers, LP108,900$310.4K0.00%−74,400−40.6%Reduced
Voss Capital, LLC125,000$356.3K0.07%−75,000−37.5%Reduced
Stifel Financial Corp130,363$371.5K0.00%+63,707+95.6%Added
State Street Corp141,153$402.3K0.00%00.0%Unchanged
Renaissance Technologies LLC141,700$404.0K0.00%−284,447−66.7%Reduced
Morgan Stanley178,796$509.6K0.00%−76,512−30.0%Reduced
P.A.W. Capital Corp180,000$513.0K1.40%−20,000−10.0%Reduced
Gsa Capital Partners LLP188,308$537.0K0.07%−27,942−12.9%Reduced
Sigma Planning Corp192,734$549.3K0.02%+4,310+2.3%Added
Advisory Research Inc257,225$733.1K0.07%00.0%Unchanged
Silverarc Capital Management, LLC306,278$872.9K0.30%+306,278New
Geode Capital Management, LLC315,827$900.0K0.00%+17,221+5.8%Added
Carlson Capital L P365,000$1.04M0.08%−170,000−31.8%Reduced
Millennium Management LLC373,982$1.07M0.00%−66,401−15.1%Reduced
Dimensional Fund Advisors LP457,667$1.30M0.00%+3,495+0.8%Added
Robertson Stephens Wealth Management, LLC478,500$1.36M0.13%00.0%Unchanged
Monaco Asset Management SAM497,177$1.42M0.51%+38,326+8.4%Added
BlackRock Inc.702,181$2.00M0.00%−76,527−9.8%Reduced
Bleichroeder LP861,278$2.45M0.53%+306,278+55.2%Added
Vanguard Group Inc1,528,930$4.36M0.00%+6,611+0.4%Added
Prosight Management, LP1,840,510$5.25M2.93%+294,937+19.1%Added
Slate Path Capital LP2,402,455$6.85M0.37%+918,836+61.9%Added
Ergoteles LLC0$00.00%−117,074−100.0%Sold out
New York Life Investments Alternatives0$00.00%−110,614−100.0%Sold out
Two Sigma Investments, LP0$00.00%−34,102−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−28,573−100.0%Sold out
XTX Topco Ltd0$00.00%−27,449−100.0%Sold out
Marshall Wace, LLP0$00.00%−26,205−100.0%Sold out
RBF Capital, LLC0$00.00%−20,000−100.0%Sold out
Simplex Trading, LLC0$00.00%−16,400−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−15,100−100.0%Sold out
LMR Partners LLP0$00.00%−14,628−100.0%Sold out
ETF Managers Group, LLC0$00.00%−10,441−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−2,906−100.0%Sold out
Steward Partners Investment Advisory, LLC0$00.00%−300−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−400−100.0%Sold out
Royal Bank of Canada0$00.00%−219−100.0%Sold out